Botanix Pharmaceuticals Limited (AU:BOT) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Botanix Pharmaceuticals is set to present at the Bell Potter Healthcare Conference, highlighting its progress in commercializing Sofdra™, a novel treatment for primary axillary hyperhidrosis. This presentation marks an important milestone for the company as it updates investors on its sales and marketing strategies and new payer coverage initiatives. The conference will gather investors from both Australia and abroad, providing Botanix a significant platform for visibility.
For further insights into AU:BOT stock, check out TipRanks’ Stock Analysis page.